Reuters logo
BRIEF-Avadel Pharma Q3 adjusted earnings per share $0.09
2017年11月8日 / 下午12点50分 / 10 天前

BRIEF-Avadel Pharma Q3 adjusted earnings per share $0.09

Nov 8 (Reuters) - Avadel Pharmaceuticals Plc

* Avadel pharmaceuticals reports third quarter 2017 results

* Q3 adjusted earnings per share $0.09

* Q3 gaap earnings per share $0.52

* Q3 revenue $39.7 million versus i/b/e/s view $38.2 million

* Q3 earnings per share view $-0.02 -- Thomson Reuters I/B/E/S

* Sees fy 2017 adjusted earnings per share $0.25 to $0.35

* Sees fy 2017 revenue $165 million to $175 million

* Avadel pharmaceuticals plc - ‍during q4 of 2017, company expects to spend approximately $15 million on launch preparation costs for noctiva​

* Avadel pharmaceuticals - ‍ during q4 , expects to spend between $8 to $10 million in research and development costs, associated with rest-on clinical trial​

* Avadel pharmaceuticals plc - ‍for full year, research and development costs are now expected to be in range of $30 to $35 million​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below